Javier Agejas
Javier Agejas publishes mostly in Organic Chemistry, Molecular Biology and Pharmaceutical Science, on topics such as Chemical Synthesis and Analysis, Synthesis and Biological Evaluation and Phenothiazines and Benzothiazines Synthesis and Activities.
- World rank
- #3,644,133 of 7,710,434 ranked researchers
- Rank in Spain
- #82,616 of 204,306
- Works
- 21
- Citations
- 541
- Citations per work
- 25.8
What does Javier Agejas research?
Javier Agejas's work is mostly in Chemistry (52%), Biochemistry, Genetics and Molecular Biology (22%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1255.6%
- Chemistry1151.9%
- Computer Science13.7%
- Life Sciences731.5%
- Everything else29.2%
- Health Sciences13.7%
- Medicine13.7%
- 1Organic Chemistry52% of their works
- 2Molecular Biology22% of their works
- 3Pharmaceutical Science6% of their works
- 4Computational Theory and Mathematics4% of their works
- 5Pharmacology4% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Chemical Synthesis and Analysis
- Synthesis and Biological Evaluation
- Phenothiazines and Benzothiazines Synthesis and Activities
- Fluorine in Organic Chemistry
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Synthesis and Reactions of Organic Compounds
- Radical Photochemical Reactions
Which keywords describe Javier Agejas's research?
The keywords of their largest research topics: Synthesis, Catalyst, Medicinal Chemistry, Drug Discovery, Heterocycles, Peptide Synthesis, Transition Metal Catalysis and Antimicrobial Activity.
- Phenothiazines
- Oxazolones
- Organic Synthesis
- Fluorine
- C–H Activation
- Biological Activities
- Antimicrobial Activity
- Peptide Synthesis
- Drug Discovery
- Catalyst
- Synthesis
- Medicinal Chemistry
- Heterocycles
- Transition Metal Catalysis
- Quinoxaline
- Carbon–Carbon Bond Formation
- Enantioselective Reactions
- Imidazoles
- Organocatalysis
- Pharmaceuticals
- Visible Light Photoredox Catalysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis73 topics
- Catalyst52 topics
- Medicinal Chemistry52 topics
- Drug Discovery41 topic
- Heterocycles42 topics
- Peptide Synthesis41 topic
- Transition Metal Catalysis42 topics
- Antimicrobial Activity31 topic
- Quinoxaline31 topic
- Biological Activities21 topic
- Carbon–Carbon Bond Formation21 topic
- C–H Activation21 topic
- Enantioselective Reactions21 topic
- Fluorine21 topic
- Imidazoles21 topic
- Organic Synthesis21 topic
- Organocatalysis21 topic
- Oxazolones21 topic
- Pharmaceuticals21 topic
- Phenothiazines21 topic
- Visible Light Photoredox Catalysis21 topic
Where does Javier Agejas work?
Javier Agejas's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does Javier Agejas have?
OpenAlex counts 21 works and 541 citations for Javier Agejas, an h-index of 10, ranking #3,644,133 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Javier Agejas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.